|
Index of reports
> Cases with Thrombocytopenia (9)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Valcyte (Valganciclovir) where reactions include thrombocytopenia. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Valcyte side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27
Patient: female, weighing 54.1 kg (119.0 pounds)
Reactions: Pneumonia Primary Atypical, Diarrhoea, Hypotension, Cytomegalovirus Viraemia, Pyrexia, Thrombocytopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Certican
Dosage: 1.5 mg, bid
Administration route: Oral
Start date: 2011-02-03
End date: 2011-09-09
Certican
Dosage: 0.75 mg, bid
Administration route: Oral
Indication: Renal Transplant
Start date: 2011-01-28
End date: 2011-02-02
Certican
Dosage: 0.75 mg, bid
Administration route: Oral
Start date: 2011-09-10
End date: 2012-01-17
Leflunomide
Mycophenolate Mefetil
Dosage: 250 mg, bid
Administration route: Oral
Indication: Renal Transplant
Start date: 2012-01-24
End date: 2012-01-29
Prednisone TAB
Dosage: 2.5 mg, qd
Administration route: Oral
Indication: Renal Transplant
Start date: 2011-01-28
Prednisone TAB
Indication: Immunosuppression
Prograf
Dosage: 0.5 mg, bid
Administration route: Oral
Indication: Renal Transplant
Start date: 2011-01-28
Prograf
Indication: Immunosuppression
Valcyte
Dosage: 450 mg, bid
Administration route: Oral
Indication: Cytomegalovirus Viraemia
Start date: 2011-08-25
Other drugs received by patient: Lasix
Possible Valcyte side effects in female
Reported by a physician from United States on 2012-07-27
Patient: female, weighing 54.1 kg (119.0 pounds)
Reactions: Pneumonia Primary Atypical, Diarrhoea, Hypotension, Cytomegalovirus Viraemia, Pyrexia, Thrombocytopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Certican
Dosage: 1.5 mg, bid
Administration route: Oral
Start date: 2011-02-03
End date: 2011-09-09
Certican
Dosage: 0.75 mg, bid
Administration route: Oral
Indication: Renal Transplant
Start date: 2011-01-28
End date: 2011-02-02
Certican
Dosage: 0.75 mg, bid
Administration route: Oral
Start date: 2011-09-10
Leflunomide
Mycophenolate Mofetil
Dosage: 250 mg, bid
Administration route: Oral
Indication: Renal Transplant
Start date: 2012-01-24
End date: 2012-01-29
Prednisone
Indication: Immunosuppression
Prednisone
Dosage: 2.5 mg, qd
Administration route: Oral
Indication: Renal Transplant
Start date: 2011-01-28
Prograf
Dosage: 01 mg, bid
Administration route: Oral
Indication: Renal Transplant
Start date: 2011-01-28
Prograf
Indication: Immunosuppression
Valcyte
Dosage: 450 mg, bid
Administration route: Oral
Indication: Cytomegalovirus Viraemia
Start date: 2011-08-25
Other drugs received by patient: Lasix
Possible Valcyte side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-16
Patient:
Reactions: Febrile Neutropenia, Neutropenia, Thrombocytopenia
Drug(s) suspected as cause:
Ganciclovir Sodium
Indication: Cytomegalovirus Infection
Valcyte
Administration route: Oral
Indication: Cytomegalovirus Infection
Other drugs received by patient: Trimethoprim + Sulfamethoxazole; Acyclovir
Possible Valcyte side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-01
Patient: female, weighing 54.1 kg (119.0 pounds)
Reactions: Diarrhoea, Hypotension, Cytomegalovirus Viraemia, Pyrexia, Thrombocytopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Certican
Dosage: 0.75 mg, bid
Administration route: Oral
Start date: 2011-09-10
End date: 2012-01-16
Certican
Dosage: 0.75 mg, bid
Administration route: Oral
Indication: Renal Transplant
Start date: 2011-01-29
End date: 2011-02-02
Certican
Dosage: 1.5 mg, bid
Administration route: Oral
Start date: 2011-02-03
End date: 2011-09-09
Leflunomide
Prednisone TAB
Dosage: 2.5 mg, qd
Administration route: Oral
Indication: Renal Transplant
Start date: 2011-01-28
Prograf
Dosage: 01 mg, bid
Administration route: Oral
Indication: Renal Transplant
Start date: 2011-01-28
End date: 2012-01-16
Valcyte
Dosage: 450 mg, bid
Administration route: Oral
Indication: Cytomegalovirus Viraemia
Start date: 2011-08-25
Other drugs received by patient: Lasix
Possible Valcyte side effects in male
Reported by a physician from France on 2012-05-23
Patient: male, weighing 68.0 kg (149.6 pounds)
Reactions: Complications of Transplanted Kidney, Wound Dehiscence, Malnutrition, Bronchial Obstruction, Anastomotic Haemorrhage, Renal Impairment, Unevaluable Event, Culture Wound Positive, Thrombocytopenia, Escherichia Sepsis
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Basiliximab
Indication: Transplant Rejection
Start date: 2011-01-15
End date: 2011-01-15
Cellcept
Dosage: permanently discontinued. date of last dose prior to sae: 08 march 2011.
Administration route: Oral
Start date: 2011-03-01
End date: 2011-03-08
Cellcept
Dosage: frequency: everyday. temporarily interrupted
Administration route: Oral
Indication: Transplant Rejection
Start date: 2011-01-15
End date: 2011-02-09
Cyclophosphamide
Administration route: Oral
Indication: Transplant Rejection
Start date: 2011-01-17
End date: 2011-02-01
Cyclosporine
Cyclosporine
Esomeprazole Magnesium
Start date: 2011-01-16
End date: 2011-02-01
Everolimus
Indication: Product Used FOR Unknown Indication
Start date: 2011-02-02
End date: 2011-02-09
Methylprednisolone and Methylprednisolone
Indication: Transplant Rejection
Start date: 2011-01-15
End date: 2011-01-15
Prednisone TAB
Administration route: Oral
Indication: Transplant Rejection
Prednisone TAB
Dosage: date of last dose prior to sae: 16 march 2011.
Administration route: Oral
Ranitidine HCL
Start date: 2011-02-02
End date: 2011-02-09
Sulfamethoxazole and Trimethoprim
Start date: 2011-01-24
End date: 2011-02-01
Valcyte
Dosage: twice a week
Start date: 2011-01-29
End date: 2011-02-01
Other drugs received by patient: Adancor; Amlodipine Besylate; Insulatard NPH Human; Econazole Nitrate; Potassium Chloride; Adancor; Imodium; Alfuzosin HCL; Calcidia; Aspirin; Mirtazapine; Calcidia; Lasix; Eprex; Nitroderm; Potassium Chloride; Amoxicillin; Lasix; Sodium Bicarbonate; Aluminum Hydroxide and Magnesium Trisilicate
Possible Valcyte side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-20
Patient: female, weighing 54.1 kg (119.0 pounds)
Reactions: Diarrhoea, Hypotension, Cytomegalovirus Viraemia, Pyrexia, Thrombocytopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Certican
Dosage: 0.75 mg, bid
Administration route: Oral
Indication: Renal Transplant
Start date: 2011-01-28
End date: 2011-02-02
Certican
Dosage: 1.5 mg, bid
Administration route: Oral
Start date: 2011-02-03
End date: 2011-09-09
Certican
Dosage: 0.75 mg, bid
Administration route: Oral
Start date: 2011-09-10
End date: 2012-01-16
Leflunomide
Prednisone
Dosage: 2.5 mg, qd
Administration route: Oral
Indication: Renal Transplant
Start date: 2011-01-28
Prograf
Dosage: 01 mg, bid
Administration route: Oral
Indication: Renal Transplant
Start date: 2011-01-28
End date: 2012-01-16
Valcyte
Dosage: 450 mg, bid
Administration route: Oral
Indication: Cytomegalovirus Viraemia
Start date: 2011-08-25
Other drugs received by patient: Lasix
Possible Valcyte side effects in female
Reported by a physician from United States on 2012-01-20
Patient: female, weighing 54.1 kg (119.0 pounds)
Reactions: Diarrhoea, Hypotension, Cytomegalovirus Viraemia, Pyrexia, Thrombocytopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Certican
Dosage: 1.5 mg, bid
Administration route: Oral
Start date: 2011-02-03
End date: 2011-09-09
Certican
Dosage: 0.75 mg, bid
Administration route: Oral
Indication: Renal Transplant
Start date: 2011-01-28
End date: 2011-02-02
Certican
Dosage: 0.75 mg, bid
Administration route: Oral
Start date: 2011-09-10
End date: 2012-01-16
Leflunomide
Prednisone TAB
Dosage: 2.5 mg, qd
Administration route: Oral
Indication: Renal Transplant
Start date: 2011-01-28
Prograf
Dosage: 01 mg, bid
Administration route: Oral
Indication: Renal Transplant
Start date: 2011-01-28
Valcyte
Dosage: 450 mg, bid
Administration route: Oral
Indication: Cytomegalovirus Viraemia
Start date: 2011-08-25
Other drugs received by patient: Lasix
Possible Valcyte side effects in female
Reported by a physician from Finland on 2011-12-29
Patient: female
Reactions: Anaemia, Hepatic Enzyme Increased, Interstitial Lung Disease, Diarrhoea, Staphylococcal Infection, Aspergillosis, Cytomegalovirus Infection, Neutropenia, Blood Creatinine Increased, Sinusitis, Thrombocytopenia, Soft Tissue Neoplasm, Herpes Virus Infection, Leukopenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Alemtuzumab
Indication: Chronic Lymphocytic Leukaemia
Cyclophosphamide
Indication: Chronic Lymphocytic Leukaemia
Fludarabine Phosphate
Indication: Chronic Lymphocytic Leukaemia
Foscavir
Indication: Cytomegalovirus Infection
Mabthera
Indication: Chronic Lymphocytic Leukaemia
Valcyte
Administration route: Oral
Indication: Cytomegalovirus Infection
Start date: 2010-04-26
Other drugs received by patient: Cyclosporine; Fluconazole; Emgesan; Valtrex; Ratiograstim; Lansoprazole; Prednisone TAB; Neulasta; Ceftazidime; Ribavirin; Hydrocortisone; Gensumycin; Ditrim Duplo; Multitabs; Calcium Carbonate; Adursal; Avelox; Tenox; Ceftriaxone; Mycophenolate Mofetil (Cellcept); Vitamin C; Ceftazidime; Medrol; Pulmicort; Zithromax; Diflucan
Possible Valcyte side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-28
Patient: male, weighing 69.4 kg (152.7 pounds)
Reactions: Pneumonia, Ischaemic Hepatitis, Transaminases Increased, Thrombocytopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Certican
Dosage: 0.75 mg, q12h
Start date: 2011-06-25
Certican
Dosage: 1.5 mg, q12h
Indication: Renal Transplant
Start date: 2011-03-22
Norvasc
Prograf
Dosage: 1 mg, q12h
Administration route: Oral
Indication: Renal Transplant
Start date: 2011-03-21
Valcyte
|
